Related Experiment Video
Updated: Jul 23, 2025

A Two-Step Strategy that Combines Epigenetic Modification and Biomechanical Cues to Generate Mammalian Pluripotent Cells
Published on: August 29, 2020
Restricting epigenetic activity promotes the reprogramming of transformed cells to pluripotency in a line-specific
Xiuling Fu1, Qiang Zhuang1, Isaac A Babarinde1
1Department of Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, 518055, China.
Abstract:
Somatic cell reprogramming and oncogenic transformation share surprisingly similar features, yet transformed cells are resistant to reprogramming. Epigenetic barriers must block transformed cells from reprogramming, but the nature of those barriers is unclear. In this study, we generated a systematic panel of transformed mouse embryonic fibroblasts (MEFs) using oncogenic transgenes and discovered transformed cell lines compatible with reprogramming when transfected with Oct4/Sox2/Klf4/Myc. By comparing the reprogramming-capable and incapable transformed lines we identified multiple stages of failure in the reprogramming process. Some transformed lines failed at an early stage, whilst other lines seemed to progress through a conventional reprogramming process. Finally, we show that MEK inhibition overcomes one critical reprogramming barrier by indirectly suppressing a hyperacetylated active epigenetic state. This study reveals that diverse epigenetic barriers underly resistance to reprogramming of transformed cells.
Insights
Transformed cells resist reprogramming due to epigenetic barriers. This study identified diverse barriers and showed MEK inhibition can overcome one, enabling reprogramming of some cancer cells.
Area of Science:
- Cell biology
- Epigenetics
- Cancer research
Background:
- Somatic cell reprogramming and oncogenic transformation share similarities.
- Transformed cells are generally resistant to reprogramming.
- The nature of epigenetic barriers blocking reprogramming in transformed cells is not well understood.
Purpose of the Study:
- To investigate the epigenetic barriers preventing reprogramming in oncogenically transformed cells.
- To identify factors and stages contributing to reprogramming resistance.
- To explore strategies for overcoming reprogramming resistance in transformed cells.
Main Methods:
- Generated a panel of oncogenically transformed mouse embryonic fibroblasts (MEFs).
- Transfected transformed MEFs with reprogramming factors (Oct4/Sox2/Klf4/Myc).
- Compared reprogramming-capable and incapable transformed lines; utilized MEK inhibition.
Main Results:
- Identified transformed cell lines capable of reprogramming upon Oct4/Sox2/Klf4/Myc transfection.
- Discovered multiple reprogramming failure stages in resistant transformed lines.
- Demonstrated MEK inhibition overcomes a reprogramming barrier by suppressing a hyperacetylated epigenetic state.
Conclusions:
- Diverse epigenetic barriers underlie the resistance of transformed cells to reprogramming.
- Understanding these barriers is crucial for advancing reprogramming technologies.
- Targeting specific epigenetic states, like those modulated by MEK inhibition, can restore reprogramming capacity.
Related Concept Videos
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Somatic to iPS Cell Reprogramming
Methods of Nuclear Reprogramming
Introduction to Nuclear Reprogramming
Maintenance of the ES Cell State
Epigenetic Regulation
X-chromosome...

